(Q44158871)

30 November 2017

title

Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer (English)

1 reference

positron emission tomography

30 November 2017

0 references

1 reference

Hiroyuki Kato

1

1 reference

30 November 2017

Hiroyuki Kuwano

2

1 reference

30 November 2017

Masanobu Nakajima

3

1 reference

30 November 2017

Tatsuya Miyazaki

4

1 reference

30 November 2017

Minako Yoshikawa

5

1 reference

30 November 2017

Norihiro Masuda

6

1 reference

30 November 2017

Minoru Fukuchi

7

1 reference

30 November 2017

Ryokuhei Manda

8

1 reference

30 November 2017

Katsuhiko Tsukada

9

1 reference

30 November 2017

Noboru Oriuchi

10

1 reference

30 November 2017

Keigo Endo

11

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

The American Journal of Surgery

30 November 2017

published in

1 reference

30 November 2017

volume

184

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

279-283

1 reference

Diagnosis and treatment of esophageal neoplasms

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Oesophageal cancer: hope for the future?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Response to chemotherapy in esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

7 January 2021

PET imaging in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Improvement in staging of esophageal cancer with the addition of positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Positron emission tomography for staging of oesophageal and gastroesophageal malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Preoperative hyperthermia combined with chemotherapy and irradiation for the treatment of patients with esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Relationship between the expression of HLA-DR antigen and the effectiveness of preoperative hyperthermo-chemo-radiotherapy in oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Response of Osteosarcoma to Chemotherapy. Evaluation with F-18 FDG-PET Scans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900932-7

10.1016/S0002-9610(02)00932-7

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference